2022
DOI: 10.1080/07391102.2022.2046166
|View full text |Cite
|
Sign up to set email alerts
|

An integrated computational approach to screening of alkaloids inhibitors of TBX3 in breast cancer cell lines

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 73 publications
0
3
0
Order By: Relevance
“…The physiological condition of the simulation was 310 K and 1.013 bar, which mimics the physiological state of the human cell. 56 , 57 The energies and structures were recorded every 100 ps and saved in the trajectory, where 1000 frames were generated throughout the simulation. The Simulation Interaction Diagram module then examined the trajectories to investigate the root-mean-square deviation (RMSD), root-mean-square fluctuation (RMSF), 3D structure, and protein-ligand contact.…”
Section: Methodsmentioning
confidence: 99%
“…The physiological condition of the simulation was 310 K and 1.013 bar, which mimics the physiological state of the human cell. 56 , 57 The energies and structures were recorded every 100 ps and saved in the trajectory, where 1000 frames were generated throughout the simulation. The Simulation Interaction Diagram module then examined the trajectories to investigate the root-mean-square deviation (RMSD), root-mean-square fluctuation (RMSF), 3D structure, and protein-ligand contact.…”
Section: Methodsmentioning
confidence: 99%
“…Concerning chemical reagents, an integrated computational approach indicated that two alkaloids, Jervine and Diflomotecan, can form stable complexes with TBX3 and suggested them as new effective drugs against breast cancers[ 63 ]. In another study, an aqueous extract of Fructus ligustri lucidi, a common Chinese herbal medicine, was reported to suppress TBX3 and enhance sensitivity to doxorubicin in colon cancer cells[ 64 ].…”
Section: Tbx3 As a Therapeutic Targetmentioning
confidence: 99%
“…Amir and colleagues reported that microRNA-206 suppressed TBX3 and, as a result, inhibited tumor growth of breast cancer organoids [ 62 ], which suggests the possibility that this microRNA could also regulate TBX3 in aging-related gastric cancers. With respect to the chemical inhibitor of TBX3, Paul and colleagues recently discovered that two alkaloids Jervine and Diflomotecan were able to form stable complexes with TBX3 through an integrated computational approach and that these two alkaloids could become new effective drugs for breast cancers [ 63 ]. Given their effect on TBX3, these two alkaloids may also be effective in treating aging-related gastric cancers.…”
Section: Future Perspectivesmentioning
confidence: 99%